Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 12/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 12/20 | 0.47 |
| ▸ | WNT1 | P04628 | 11/20 | 0.47 |
| ▸ | KIT | P10721 | 5/20 | 0.42 |
| ▸ | CSF1R | P07333 | 1/20 | 0.42 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30690608 | 0.96 | GSK3B (0.43) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690666 | 0.95 | KIT (0.42) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690660 | 0.94 | KIT (0.42) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690513 | 0.94 | KIT (0.42) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690437 | 0.94 | KIT (0.42) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690667 | 0.93 | KIT (0.42) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690511 | 0.93 | KIT (0.43) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690501 | 0.92 | GSK3B (0.45) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690716 | 0.92 | GSK3B (0.45) | GSK3BDYRK1AWNT1KITCSF1R | |
| SCHEMBL30690702 | 0.91 | KIT (0.43) | GSK3BDYRK1AWNT1KITCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023247593-A1 | PYRROLOPYRIDINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2023-12-28 | — | — | WO | claimed |